Chong Kun Dang Pharmaceutical Corp.

République de Corée


Commandez votre montre hebdomadaire Chong Kun Dang Pharmaceutical Corp.
Quantité totale PI 236
Rang # Quantité totale PI 5 614
Note d'activité PI 3/5.0    137
Rang # Activité PI 4 916
Symbole boursier 185750 (krx)
ISIN KR7185750007
Capitalisation 1.2T  (KRW)
Industrie Drug Manufacturers - Specialty & Generic
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

60 3
34 0
138 0
1
 
Dernier brevet 2025 - Pharmaceutical combination formu...
Premier brevet 1996 - Camptothecin derivatives and its...
Dernière marque 2024 - LIQUISTAL
Première marque 2021 - LIQUISTAL

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Pharmaceutical combination formulation comprising atorvastatin and ezetimibe. The present inventi...
Invention Pharmaceutical combination formulation comprising sitagliptin and empagliflozin and preparing met...
Invention Compound as parp1 inhibitor and pharmaceutical composition comprising the same. The present inven...
Invention Glp-1 receptor agonist, and uses thereof. The present invention relates to a compound having a no...
2024 Invention Anti-cancer combination comprising anti-c-met antibody. The present invention relates to a combin...
Invention Anti-cancer combination comprising anti-c-met antibody. The present invention relates to: a combi...
Invention Novel crystal form of tegoprazan sulfonic acid salt and pharmaceutical composition comprising the...
P/S Hormone replacement therapy preparations; Hormone suppressing preparations; Hormones for medical ...
Invention New preparation method of compound and new crystalline form. The present invention relates to a n...
Invention Novel immunoconjugate targeting c-met and use thereof. The present disclosure relates to an immun...
Invention Oxadiazole derivative compounds, and the pharmaceutical composition comprising the same. The pres...
Invention Pharmaceutical composite formulation comprising lobeglitazone and sitagliptin. Provided is a phar...
Invention Pharmaceutical composition for prevention or treatment of dry eye syndrome comprising lifitegrast...
Invention Pharmaceutical composition with improved stability comprising tenofovir alafenamide or pharmaceut...
2023 Invention Compositions for preventing and treating renal failure (rf). The present invention relates to a p...
Invention Composition for preventing or treating gastritis or peptic ulcer. Cinnamomum cassia with a non-po...
Invention Stable antibody composition. The present disclosure relates to an aqueous pharmaceutical composit...
Invention Sulfoximine compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprisi...
Invention Composition and combination therapy for treatment of type 2 diabetes mellitus. The present invent...
Invention Pharmaceutical composition comprising sacubitril valsartan calcium salt. The pharmaceutical compo...
Invention 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and uses thereof. The p...
Invention 1,3,4-oxadiazole triazole compounds as histone deacetylase 6 inhibitor, and pharmaceutical compos...
Invention Compositions for preventing or treating idiopathic pulmonary fibrosis (ipf). The present disclos...
Invention Compositions for preventing or treating idiopathic pulmonary fibrosis (ipf). The present disclosu...
Invention Composition, comprising cinnamomum cassia extract having innovative ckd extraction technology (ic...
Invention Compositions for preventing or treating heart failure (hf). The present invention relates to a p...
Invention Compositions for preventing or treating pulmonary arterial hypertension. The present invention r...
Invention Compositions for preventing or treating pulmonary arterial hypertension. The present invention re...
Invention Compositions for preventing or treating heart failure (hf). The present invention relates to a ph...
Invention Carvedilol sustained release tablet with improved compliance through reduction of tablet size usi...
2022 Invention Pharmaceutical combination which has improved convenience for internal use through size reduction...
Invention Method for producing high-purity triglyceride derivatives containing high content of eicosapentae...
Invention Compositions for preventing or treating charcot-marie-tooth disease (cmt). The present invention...
Invention Compound as adenosine a2a receptor antagonist and pharmaceutical composition comprising same. Th...
Invention 1,3,4-oxadiazole thiocarbonyl compounds as histone deacetylase 6 inhibitor, and pharmaceutical co...
2021 Invention Composition for preventing, improving or treating gastritis or peptic ulcer comprising extract of...
Invention Acid addition salt of indene derivative prodrug and method for preparing same. The present inven...
Invention Novel compounds as histone deacetylase 6 inhibitor, and pharmaceutical composition comprising the...
Invention Injectable composition comprising gnrh analogue. An injectable composition of the present invent...
Invention Donepezil ether palmitate or pharmaceutically acceptable salt thereof. The present invention rel...
P/S Pharmaceuticals preparations for the treatment and prevention of iron deficiency and anemia; phar...
Invention 1,3,4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutical ...
Invention Pharmaceutical composition comprising esomeprazole and sodium bicarbonate having excellent releas...
P/S Pharmaceutical preparations; Pharmaceutical preparations for the treatment of pubertas praecox; p...
P/S Pharmaceutical preparations for the treatment of pubertas praecox; pharmaceutical preparations fo...
2020 Invention Compositions for preventing or treating chronic obstructive pulmonary diseases (copd). The prese...
Invention 1, 3, 4-oxadiazole derivative compounds as histone deacetylase 6 inhibitor, and the pharmaceutica...
Invention 1,3,4-oxadiazole homophthalimide derivative compounds as histone deacetylase 6 inhibitor, and the...